Technological Innovations in Behavioral Treatments for Cigarette Smoking

NCT ID: NCT00926939

Last Updated: 2015-04-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

96 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-06-30

Study Completion Date

2014-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to evaluate a sustainable and broadly accessible treatment delivery model (Motiv8) for smoking cessation based on abstinence-reinforcement.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Smokers are randomly assigned to one of two groups: an Abstinence Contingent (AC) group and a Submission Contingent (SC) group. The AC group receives vouchers for abstaining from smoking (measured by a carbon monoxide monitor and confirmed through video-submission), and the SC group receives vouchers for submitting videos of their carbon monoxide breath tests. Both groups take videos of their CO-monitoring on a secure website designed for the study, as well as receive standard care counseling and education related to smoking cessation. The main intervention lasts four weeks, and a three-week maintenance phase will follow. Assessments will be conducted at intake, week four (end of the main treatment phase), and at three and six months after the intervention period is completed

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cigarette Smoking

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Abstinence Contingent (AC)

This group will receive vouchers contingent on smoking reduction and smoking abstinence (confirmed through video submissions). Abstinence is defined as a CO sample of 4ppm or less.

Group Type EXPERIMENTAL

Reinforcement for the abstinence of smoking

Intervention Type BEHAVIORAL

Participants in this intervention group will receive vouchers contingent upon a CO sample of 4ppm or less.

Submission Contingent (SC)

This group receives vouchers for submitting videos of their CO breath test.

Group Type EXPERIMENTAL

Reinforcement for submission of videos with CO sample

Intervention Type BEHAVIORAL

This intervention group will receive vouchers contingent on their submission of videos of their CO breath tests.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reinforcement for the abstinence of smoking

Participants in this intervention group will receive vouchers contingent upon a CO sample of 4ppm or less.

Intervention Type BEHAVIORAL

Reinforcement for submission of videos with CO sample

This intervention group will receive vouchers contingent on their submission of videos of their CO breath tests.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Self-reported smoker
* Permission to contact applicant by phone
* Ability to use the internet

Exclusion Criteria

* Self-report of a history of or current severe or unstable medical or psychiatric illness that would interfere with the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role collaborator

National Development and Research Institutes, Inc.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jesse Dallery

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jesse Dallery, PhD

Role: PRINCIPAL_INVESTIGATOR

National Development and Research Institutes, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Development and Research Institutes

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01DA023469

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R01DA023469

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Researching the Youth Smoking Experience
NCT00156702 COMPLETED PHASE1
Smoking Treatment of Prisoners
NCT00110630 COMPLETED PHASE3
Early Tobacco Abstinence - 5
NCT00224965 TERMINATED PHASE1